Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: AIDS Behav. 2020 Nov;24(11):3264–3278. doi: 10.1007/s10461-020-02900-7

Table 6.

Parameter estimates for change in outcomes over time

Study outcomea Tests of linear trends
Time period Estimate (SE) LRTa
Wisepill adherence
 Active treatment Weekly (baseline to 4-month) 0.14 (0.44) χ2(2) = 22.15**
 Follow up Weekly (4-month to 8-month) − 1.33 (0.69) χ2(2) = 56.42**
Self-report adherence
 Active treatment Weekly (treatment phase) 0.06 (0.02)** χ2(2) = 1.81
 Full study period Major assessments only 0.87 (0.30)** χ2(2) = 5.18
Positive affect
 Active treatment Weekly (treatment phase) 0.16 (0.11) χ2(2) = 29.24**
Negative affect
 Active treatment Weekly (treatment phase) − 0.28 (0.06)** χ2(2) = 1.26
Study outcomeb Non-linear comparisons
Baseline vs. 4-month Baseline vs. 8-month
Log PVL − 1.13 (0.30)** − 0.93 (0.32)**
Positive affect 3.43 (1.77) 3.84 (1.80)*
Negative affect − 4.34 (1.35)** − 0.77 (1.37)
PHQ depression − 1.87 (1.03) − 1.60 (1.05)

The HLM parameter estimates are reported, followed by the standard error in parentheses

a

The results of the LRT determine whether we retained a fixed effects only model or if we retained the random effects as well for the linear test. A significant finding on the LRT means that we included the fixed and random effects in the linear test

b

Reference = baseline

*

Significant at p < .05

**

Significant at p < .01